Lotus Pharmaceuticals Financials
| LTUS Stock | USD 0.01 0 40.00% |
Lotus |
Understanding current and past Lotus Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Lotus Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Lotus Pharmaceuticals' assets may result in an increase in income on the income statement.
The data published in Lotus Pharmaceuticals' official financial statements usually reflect Lotus Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Lotus Pharmaceuticals. For example, before you start analyzing numbers published by Lotus accountants, it's critical to develop an understanding of what Lotus Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Lotus Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lotus Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Lotus Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Lotus Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Lotus Pharmaceuticals' management manipulating its earnings.
Lotus Pharmaceuticals Stock Summary
Lotus Pharmaceuticals competes with TortoiseEcofin Acquisition, Learn CW, Leo Holdings, Trajectory Alpha, and Generation Asia. Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the Peoples Republic of China. Lotus Pharmaceutical operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 233 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US5457152032 |
| Business Address | 813 Blue Ridge |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | lotuspharmaceuticalsusa.com |
| Phone | 615 310 2688 |
| Currency | USD - US Dollar |
You should never invest in Lotus Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Lotus Pink Sheet, because this is throwing your money away. Analyzing the key information contained in Lotus Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Lotus Pharmaceuticals Key Financial Ratios
Generally speaking, Lotus Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Lotus Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Lotus Pharmaceuticals over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Lotus Pharmaceuticals reports annually and quarterly.Lotus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Lotus Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Lotus Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lotus Pharmaceuticals competition to find correlations between indicators driving Lotus Pharmaceuticals's intrinsic value. More Info.Lotus Pharmaceuticals is currently regarded as number one stock in return on equity category among related companies. It is currently regarded as number one stock in return on asset category among related companies reporting about 2.51 of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value Lotus Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Lotus Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lotus Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Lotus Pharmaceuticals Systematic Risk
Lotus Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Lotus Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Lotus Pharmaceuticals correlated with the market. If Beta is less than 0 Lotus Pharmaceuticals generally moves in the opposite direction as compared to the market. If Lotus Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Lotus Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Lotus Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Lotus Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
About Lotus Pharmaceuticals Financials
What exactly are Lotus Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Lotus Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential Lotus Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Lotus Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Lotus Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Lotus Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Lotus Pharmaceuticals Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Lotus Pharmaceuticals is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Lotus has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Lotus Pharmaceuticals' financials are consistent with your investment objective using the following steps:- Review Lotus Pharmaceuticals' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Lotus Pharmaceuticals' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Lotus Pharmaceuticals' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Lotus Pharmaceuticals' stock is overvalued or undervalued.
Lotus Pharmaceuticals April 19, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Lotus Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Lotus Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lotus Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Lotus Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lotus Pharmaceuticals's daily price indicators and compare them against related drivers.
| Downside Deviation | 25.97 | |||
| Information Ratio | 0.133 | |||
| Maximum Drawdown | 121.67 | |||
| Value At Risk | (11.29) | |||
| Potential Upside | 27.91 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lotus Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Lotus Pink Sheet analysis
When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |